Thomson Reuters (TRI, TRI.TO) announced that it has acquired GeneGo for undisclosed financial terms. Thomson Reuters said that GeneGo will become part of the Healthcare & Science business of Thomson Reuters, effective immediately.
Thomson Reuters said that this acquisition enables it to provide pharmaceutical, biotechnology and academic research communities with solutions that provide better understanding of underlying mechanism of disease and potential therapies.
GeneGo is a provider of biology and disease information, analytics, and decision support solutions for pharmaceutical research and development. GeneGo is headquartered in San Diego and has offices in Moscow and Michigan.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.